Amicus Therapeutics Inc. buy Cantor Fitzgerald
Start price
15.01.25
/
50%
€9.00
Target price
15.01.26
€20.29
Performance (%)
-41.67%
Price
08.07.25
€5.10
Summary
This prediction is currently active. Massive losses of -41.67% have been the result for the BUY prediction by Cantor_Fitzgerald. This prediction currently runs until 15.01.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amicus Therapeutics Inc. | 7.292% | 7.292% |
iShares Core DAX® | 2.260% | -0.347% |
iShares Nasdaq 100 | 1.556% | 1.445% |
iShares Nikkei 225® | -0.807% | 0.603% |
iShares S&P 500 | 1.006% | 0.961% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $21.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
07.11.24
07.11.24
€19.47
07.11.25
07.11.25
-48.00%
08.07.25
08.07.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
20.09.24
20.09.24
€17.90
20.09.25
20.09.25
-47.50%
08.07.25
08.07.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.80
29.02.24
29.02.24
€20.36
28.02.25
28.02.25
-24.15%
01.03.25
01.03.25